Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Université de Montréal
$105,000.00
A Socio-Ethical Study of Personalized Health Interventions (PHI): The Case of Pharmacogenomics and Nutrigenomics
FY 2008-09
Summary
There is large person-to-person variability in outcome (benefits/risks) of health interventions such as drug therapy and nutrition. For example, only about 50% of patients respond to their prescribed medicines, while adverse drug reactions rank as the fourth leading cause of death, ahead of diabetes and pneumonia. Hence, following the completion of the Human Genome Project in 2003, the concept of personalized health interventions (PHI) has emerged. My interdisciplinary graduate training centres on applied ethics research concerning two complementary and timely innovations that enable PHI (pharmacogenomics and nutrigenomics). Pharmacogenomics is the study of genetic factors that influence variability in drug response and toxicity. Nutrigenomics aims to individualize nutrition based on human genomic variation. Although there is a large body of ethics literature on the role of source of research funding for publication bias in reporting of clinical trials, the crucial bioethics research on conflict of interests in reporting of clinical pharmacogenomics findings has not been conducted to date. In addition, there are intensive nutrigenomics bioscience efforts in both preclinical and clinical research domains. Hence, nutrigenomics raises research ethics issues that are yet to be addressed. The objective of my proposed doctoral project is to develop an empirical ethics foundation on pharmacogenomics and nutrigenomics science, while establishing a timely basis for future prospective policy-making in PHI.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
184549
Name
Stenne Raphaelle
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
A Socio-Ethical Study of Personalized Health Interventions (PHI): The Case of Pharmacogenomics and Nutrigenomics
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Applied Ethics; Conflict Of Interests; Ethical-Legal-Social-Issues (Elsi); Health Technology Assessment; Nutrigenomics Ethics; Personalized Medicine Ethics; Pharmacogenomics Ethics; Publication Bias/Ethics; Research Ethics; Science And Society Interaction
Abstract
There is large person-to-person variability in outcome (benefits/risks) of health interventions such as drug therapy and nutrition. For example, only about 50% of patients respond to their prescribed medicines, while adverse drug reactions rank as the fourth leading cause of death, ahead of diabetes and pneumonia. Hence, following the completion of the Human Genome Project in 2003, the concept of personalized health interventions (PHI) has emerged. My interdisciplinary graduate training centres on applied ethics research concerning two complementary and timely innovations that enable PHI (pharmacogenomics and nutrigenomics). Pharmacogenomics is the study of genetic factors that influence variability in drug response and toxicity. Nutrigenomics aims to individualize nutrition based on human genomic variation. Although there is a large body of ethics literature on the role of source of research funding for publication bias in reporting of clinical trials, the crucial bioethics research on conflict of interests in reporting of clinical pharmacogenomics findings has not been conducted to date. In addition, there are intensive nutrigenomics bioscience efforts in both preclinical and clinical research domains. Hence, nutrigenomics raises research ethics issues that are yet to be addressed. The objective of my proposed doctoral project is to develop an empirical ethics foundation on pharmacogenomics and nutrigenomics science, while establishing a timely basis for future prospective policy-making in PHI.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Stenne, Raphaelle
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~